Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy
Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.
Roseyknees
Agree that an informed decision should be made between patient and provider as we are not a homogenous group in terms of immune compromise related to HIV. That said, the data regarding untreated or low CD4 tell only part of the story. We need to factor advanced age and comorbidities into the picture in order to make that informed decision. Rapid and affordable anti-body testing would also help people to understand their degree of protection but unfortunately we are not there yet.
August 18, 2021 • Toronto Ontario Canada